1. Home
  2. LTRY vs NLSP Comparison

LTRY vs NLSP Comparison

Compare LTRY & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRY
  • NLSP
  • Stock Information
  • Founded
  • LTRY 2015
  • NLSP 2015
  • Country
  • LTRY United States
  • NLSP Switzerland
  • Employees
  • LTRY N/A
  • NLSP N/A
  • Industry
  • LTRY Computer Software: Prepackaged Software
  • NLSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • LTRY Technology
  • NLSP Health Care
  • Exchange
  • LTRY Nasdaq
  • NLSP Nasdaq
  • Market Cap
  • LTRY 8.8M
  • NLSP 8.2M
  • IPO Year
  • LTRY N/A
  • NLSP 2021
  • Fundamental
  • Price
  • LTRY $1.43
  • NLSP $0.21
  • Analyst Decision
  • LTRY
  • NLSP Hold
  • Analyst Count
  • LTRY 0
  • NLSP 1
  • Target Price
  • LTRY N/A
  • NLSP N/A
  • AVG Volume (30 Days)
  • LTRY 237.1K
  • NLSP 26.8M
  • Earning Date
  • LTRY 08-20-2024
  • NLSP 07-30-2024
  • Dividend Yield
  • LTRY N/A
  • NLSP N/A
  • EPS Growth
  • LTRY N/A
  • NLSP N/A
  • EPS
  • LTRY N/A
  • NLSP N/A
  • Revenue
  • LTRY $6,626,564.00
  • NLSP N/A
  • Revenue This Year
  • LTRY N/A
  • NLSP N/A
  • Revenue Next Year
  • LTRY N/A
  • NLSP N/A
  • P/E Ratio
  • LTRY N/A
  • NLSP N/A
  • Revenue Growth
  • LTRY 75.84
  • NLSP N/A
  • 52 Week Low
  • LTRY $0.82
  • NLSP $0.11
  • 52 Week High
  • LTRY $13.00
  • NLSP $1.21
  • Technical
  • Relative Strength Index (RSI)
  • LTRY 60.21
  • NLSP 56.71
  • Support Level
  • LTRY $0.92
  • NLSP $0.19
  • Resistance Level
  • LTRY $1.76
  • NLSP $0.22
  • Average True Range (ATR)
  • LTRY 0.19
  • NLSP 0.04
  • MACD
  • LTRY 0.08
  • NLSP 0.00
  • Stochastic Oscillator
  • LTRY 64.78
  • NLSP 16.67

About LTRY Lottery.com Inc.

Lottery.com Inc is a leading provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S. and international jurisdictions where the sale of lottery games is legal and its services are enabled for the remote purchase of legally sanctioned lottery games; (ii) offering an internally developed, created and operated business-to-business application programming interface of the Platform to enable commercial partners in permitted U.S.

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Share on Social Networks: